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The Journal of Immunology
A Csf1r-EGFP Transgene Provides a Novel Marker for
Monocyte Subsets in Sheep
Clare Pridans,* Gemma M. Davis,* Kristin A. Sauter,* Zofia M. Lisowski,*
Yolanda Corripio-Miyar,*,1 Anna Raper,* Lucas Lefevre,* Rachel Young,*
Mary E. McCulloch,* Simon Lillico,* Elspeth Milne,† Bruce Whitelaw,* and
David A. Hume*
Expression of Csf1r in adults is restricted to cells of the macrophage lineage. Transgenic reporters based upon the Csf1r locus
require inclusion of the highly conserved Fms-intronic regulatory element for expression. We have created Csf1r-EGFP transgenic
sheep via lentiviral transgenesis of a construct containing elements of the mouse Fms-intronic regulatory element and Csf1r
promoter. Committed bone marrow macrophage precursors and blood monocytes express EGFP in these animals. Sheep mono-
cytes were divided into three populations, similar to classical, intermediate, and nonclassical monocytes in humans, based upon
CD14 and CD16 expression. All expressed EGFP, with increased levels in the nonclassical subset. Because Csf1r expression
coincides with the earliest commitment to the macrophage lineage, Csf1r-EGFP bone marrow provides a tool for studying the
earliest events in myelopoiesis using the sheep as a model. The Journal of Immunology, 2016, 197: 000–000.
T
he development of macrophages requires signaling from
the CSF1 receptor (CSF1R) initiated by one of two li-
gands, CSF1 and IL-34 (1, 2). Expression of Csf1rmRNA
in adult mice is restricted to cells of the macrophage lineage (3).
The lineage-restricted expression of Csf1r provides the basis for
the development of macrophage-specific transgenes. MacGreen
(Csf1r-EGFP) mice were created previously by placing EGFP
expression under the control of a 7.2-kb region of the murine
Csf1r proximal promoter. Expression of the transgene is depen-
dent on the inclusion of the highly conserved Fms-intronic regu-
latory element (FIRE), located in the second intron of Csf1r (4).
MacGreen mice express EGFP in the same locations as the en-
dogenous gene and have been widely used to visualize macro-
phages (5–8). Embryonic expression of the MacGreen transgene
is restricted to macrophages and trophoblasts (4), and expression
of the latter relies on a conserved 150-bp region of the Csf1r
promoter. The trophoblast promoter region was omitted from the
construct used in the generation of the MacBlue (Csf1r-Gal4VP16/
UAS-ECFP) transgenic mice (9). In these mice, ECFP is absent
from osteoclasts and the majority of tissue macrophages, but
expression is retained in microglia and Langerhans cells (10).
MacGreen and MacBlue mice were created by standard pro-
nuclear injection techniques, a relatively inefficient gene de-
livery tool when compared with lentiviral-based methods (11). To
increase the efficiency of macrophage-specific transgene delivery,
we created a lentiviral vector containing elements of murine Csf1r
(12). The Csf1r promoter (0.5-kb including the start codon) was
fused to the coding sequence of EGFP and cloned upstream of the
intronic region containing FIRE. The lentivirus (Csf1r-EGFP-
FIRE) was capable of directing EGFP expression in mouse, rat,
human, pig, cow, sheep, and even chicken macrophages in vitro.
This remarkable cross-species reactivity led us to produce Csf1r-
EGFP sheep via injection of lentivirus into the perivitelline space
of fertilized embryos. This is a highly efficient method to generate
transgenic sheep (13). In addition to being economically impor-
tant, sheep are increasingly being used as models for human
diseases such as Huntington disease (14) and Batten disease (15).
They themselves are susceptible to a variety of diseases such as
paratuberculosis or Johne disease where macrophages are known
to play a role (16). Although ovine macrophages have been studied
in response to infection (17, 18), little is known about the charac-
teristics of their monocytic precursors. In contrast, monocyte sub-
populations have been well described in human, mouse, and pig
(reviewed in Ref. 19). In this article, we describe the generation
and characterization of Csf1r-EGFP sheep. Monocytes and their
precursors express EGFP, yet expression of the transgene is down-
regulated in differentiated macrophages. These sheep provide a
useful tool for studies involving subpopulations of monocytes and
their precursors.
Materials and Methods
Animals
Approval was obtained from The Roslin Institute’s and the University of
Edinburgh’s Protocols and Ethics Committees. The experiments were car-
ried out under the authority of a U.K. Home Office Project License under the
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regulations of the Animals (Scientific Procedures) Act 1986. Sheep and mice
were euthanized via captive bolt or CO2 asphyxiation, respectively.
Constructs and lentivirus preparation
Constructs and preparation of lentivirus (Csf1r:EGFP-FIRE) was per-
formed as described by Pridans et al. (12). The viral titer was 2.2 3 107
transducing U/ml as assayed by endpoint dilution on the D-17 cell line.
Embryo manipulation and generation of transgenic sheep
Zygotes were obtained via methods described by Ritchie et al. (20) using
abattoir-derived oocytes and frozen sperm from a Shetland ram. The len-
tivirus was injected into the perivitelline space of zygotes that were de-
veloped in vitro until the blastocyst stage (days 6–7), at which point they
were transplanted into the uterine horn of recipient ewes. The integration
of the transgene in lambs was investigated by PCR analysis of ear biopsy
DNA, amplifying EGFP using primers 59-GCACGACTTCTTCAAGTC-
CGCCATGCC-39 (forward) and 59-GCGGATCTTGAAGTTCACCTTG-
ATGCC-39 (reverse). Plasmid DNA (Csf1r:EGFP-FIRE) and genomic DNA
from a wild type sheep were used as positive and negative controls,
respectively.
Isolation of PBMCs from sheep
Bags containing citrate phosphate dextrose adenine (Infusion Concepts,
Sowerby Bridge, U.K.) were used to collect blood from live animals,1 y of
age. Blood was layered onto an equal volume of Lymphoprep (Axis-Shield,
Oslo, Norway) and centrifuged at 1200 3 g for 25 min with no brake. The
PBMC layer was washed in an equal volume of PBS containing 2% FCS
(FACS buffer). Any contaminating RBCs were removed by resuspending the
pellet in 1 ml RBC lysis buffer (BioLegend, London, U.K.) and immediately
topping up to 50 ml with FACS buffer. After centrifugation (4003 g, 5 min)
cells were washed once with buffer.
Bone marrow and alveolar macrophage isolation from sheep
Bone marrow (BM) and alveolar macrophages (AMs) were isolated as
described by Kapetanovic et al. (21), except RBC lysis buffer (BioLegend)
was used and the medium was RPMI 1640 supplemented with 20% sheep
serum, 100 U/ml penicillin, 100 mg/ml streptomycin, and 1 mmol/l Glu-
taMAX (Life Technologies, Paisley, U.K.).
In vitro differentiation of sheep macrophages
Freshly isolated BM and PBMCswere cultured on bacteriological plates at a
density of 2 3 105 and 3 3 105 cells/cm2, respectively. Complete medium
was supplemented with 104 U/ml (100 ng/ml) recombinant human CSF1
(rhCSF1; a gift from Chiron, Emeryville, CA). Fresh media containing
rhCSF1 was added on day 4 and cells analyzed on day 7.
Phagocytosis assays using macrophages and whole blood from
sheep
Freshly isolated PBMCs and BM from Csf1r-EGFP sheep were cultured in
two-well Lab-Tek chamber slides (Nunc) at a density of 5 3 105 cells/cm2
as described earlier. Zymosan A Saccharomyces cerevisiae BioParticles
labeled with Alexa Fluor (AF) 594 (Thermo Fisher Scientific, Waltham,
MA) were added at 8 3 105 particles/well and incubated for 2 h at 37˚C.
After addition of ice-cold PBS, cells were washed four times with PBS and
fixed in 4% paraformaldehyde for 20 min at room temperature. Cells were
washed in PBS and viewed by confocal microscopy. For comparison of
phagocytic activity between wild type and Csf1r-EGFP sheep, whole blood
was collected in EDTA tubes and assays performed based on a modified
protocol from Bicker et al. (22). pHrodo Red Escherichia coli BioParticles
(Thermo Fisher) were added to an equal volume of whole blood and
centrifuged at 34 3 g, 37˚C for 1 h. A control blood sample containing the
BioParticles was left on ice during this time. Samples were incubated on
ice for 10 min and then stained with mouse anti-human CD14 AF647
(clone T€UK4, 1:20; AbD Serotec, Kidlington, U.K.) for 1 h on ice. Blood
was then prepared for flow cytometry using Dako Uti-lyse erythrocyte
lysing solution according to instructions (Dako, Denmark).
Microscopy
Cells were imaged using a LSM710 confocal microscope and ZEN software
(Zeiss, Cambridge, U.K.) or via standard light microscopy.
Flow cytometry
Whole blood or PBMCs (freshly isolated or cryopreserved) from sheep were
used for analysis by flow cytometry on a FACSCalibur or Fortessa X20 (BD,
Oxford, U.K.). PBMCs were washed and stained in PBS containing 2% FCS
at 4˚C. Propidium iodide (1 mg/ml; Sigma, Dorset, U.K.) or SYTOX Blue
(Life Technologies) was used to exclude dead cells. Cells were stained with
the following primary Abs: mouse anti-human CD16 (clone KD1, 1:100;
LifeSpan BioSciences, Seattle, WA), mouse anti-bovine CD14 (clone
CC-G33, 1:400), anti-human CD14 (clone T€UK4, 1:20), mouse anti-bovine
CD172a (clone CC149, 1:200; all from AbD Serotec), and rat anti-sheep
MHC class II (clone SW73.2 [23] ascites 1:4000). Isotype controls were
used at the same concentrations as primary Abs: mouse IgG2a, IgG1-RPE,
IgG2b (AbD Serotec) and rat IgG2a (BioLegend). Secondary Abs used were
anti-mouse IgG2a-allophycocyanin (1:200), IgG1-RPE (1:800), IgG1-
allophycocyanin (1:200), IgG2b-RPE (1:400) and anti-rat IgG2a AF647
(1:4000; all from BioLegend). Blood was collected in EDTA tubes from live
sheep or from mice via cardiac bleeds. Blood was prepared for flow
cytometry using Dako Uti-lyse erythrocyte lysing solution (Dako) using
Zombie Violet (BioLegend) to exclude dead cells. CSF1-Fc (6) was labeled
with an AF647 labeling kit (Thermo Fisher Scientific). Analysis was per-
formed with FlowJo software (FlowJo, Ashland, OR).
Cell sorting and cytospins
Freshly isolated BM and PBMCs were used for sorting EGFP+ populations
on a FACSAria III cell sorter (BD). SYTOX Blue (Life Technologies) was
used to exclude dead cells. Cells were spotted on polylysine slides with a
cytocentrifuge (Shandon, Runcorn, U.K.), stained with Leishman’s stain
and mounted with DPX mounting media.
cDNA synthesis and PCR
Total RNA from sheep BM-derived macrophages (BMDMs) was isolated
using TRIzol (Invitrogen), and the aqueous phase was purified with an
RNeasy Mini kit (Qiagen). cDNAwas prepared as in Pridans et al. (12). For
standard PCR, EGFP and ovine Csf1r were amplified with Invitrogen Taq
polymerase using the following oligonucleotides: EGFP, 59-CCACAA-
GTTCAGCGTGTCC-39 and 59-CTTGTACAGCTCGTCCATGC-39; Csf1r,
59-AGTCCTGACCCTCAAACTCG-39 and 59-GGGTGAGCTTGGAGGT-
GTAT-39. For quantitative PCR, cDNA was amplified with Power SYBR
Green PCRMaster Mix using the 7500 fast Real Time PCR system (Applied
Biosystems, Thermo Fisher Scientific). The oligonucleotides used were:
Hprt 59-GACACTGGGAAGACAATGCA-39 and 59-GTCCTTTTCACCA-
GCAAGCT-39; Csf1r 59-TGGTGAAGTCCCTCAGCATC-39 and 59-CCT-
TGAATCCGCACCAGTTC-39. Primer efficiency was validated with a
standard curve of four serial dilution points (efficiency ranging between23.28
and 23.38), and tests for nonamplification of genomic DNAwere carried out
systematically. Data were normalized according to the DCq model (24).
Western blot
Radioimmunoprecipitation assay lysates (50 mM of Tris pH 7.0, 150 mM of
NaCl, 0.1% SDS, 1% IGEPAL CA-630, 1.27 mM of sodium deoxycholate)
were prepared from CSF1-starved BMDMs (1 ml per 5 3 107 cells) and
EGFP+ RAW264.7 cells (12). Samples were mixed with 43 loading dye
(0.25 M Tris-HCl pH 6.8, 8% SDS, 30% glycerol, 0.02% bromophenol blue,
10% 2-ME), heated for 5 min at 95˚C, run on a 4–12% gradient SDS-PAGE
gel, and transferred onto a polyvinylidene difluoride membrane as per Bio-
Rad instructions. The membrane was blotted using a GFP Tag mAb (Life
Technologies) and b-actin Ab (C4; Santa Cruz Biotechnology). Secondary
Abs were anti-rabbit and -mouse IgG HRP (Cell Signaling Technology).
Results
Production and screening of Csf1r-EGFP transgenic sheep
Our recent in vitro study of a lentiviral vector containing control
elements of murine Csf1r revealed macrophage-specific gene re-
porter expression in multiple species including sheep (12). Zygotes
were injected with lentivirus (Csf1r:EGFP-FIRE [12]) and devel-
oped to blastocysts in vitro to create germline transgenic Csf1r-
EGFP sheep. Eight recipient ewes were transplanted with either two
or three blastocysts, which resulted in three pregnancies. Four
founder lambs (two male and two female) were born and all were
positive for the transgene (EGFP) via confocal microscopy and
PCR (Fig. 1A). The LPS receptor CD14 is a monocyte marker (25)
and was used to initially screen the founders by flow cytometry.
Two reporter gene expression patterns were observed: all CD14+
monocytes expressed EGFP in two of the lambs (Fig. 1Bi), whereas
the other two lambs had a population of CD14+EGFP2 monocytes
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(Fig. 1Bii). There was also a small percentage of EGFPhi cells that
did not express CD14, which is discussed later (Fig. 1B). The two
founder males (as shown in Fig. 1B) were bred to wild type
Blackface ewes. Seven lambs were born to the CD14+EGFP+
founder (Fig. 1Bi), and six were positive for the transgene via PCR.
Five of these expressed detectable EGFP in blood in a preliminary
screen by flow cytometry. There was a lower percentage of off-
spring with EGFP+ monocytes born to the CD14+/2EGFP+ founder
(Fig. 1Bii). Of the 13 lambs born, 10 were EGFP+ via PCR, yet
only three expressed EGFP via flow cytometry. Although this
founder ram had a population of CD14+EGFP2 monocytes (Fig.
1Bii), analysis of the offspring’s blood revealed all CD14+ mono-
cytes expressed EGFP (data not shown). At the time of this article’s
publication, lambs were born from the F1 generation (Csf1r-EGFP
male bred with wild type ewe) and had the same phenotype as the
founders in Fig. 1Bi. All EGFP+ offspring were used in subsequent
experiments.
Analysis of BM from Csf1r-EGFP sheep
BM contains hemopoietic stem cells that create monocytes via a
series of progenitor cells (26). To determine whether EGFP was
expressed in the progenitors of monocytes within the BM of Csf1r-
EGFP sheep, we isolated cells from ribs and analyzed them by flow
cytometry. To exclude autofluorescent eosinophils (27) and other
granulocytes, we gated the marrow population on lymphocytes/
monocytes based on forward light scatter (FSC) and side scatter
of light (SSC) profiles (Fig. 2A). The small mononuclear population
had an average of 28.5% EGFP+ cells (n = 5) and could be divided
into EGFPhi and EGFPlo populations. There was an average of 1.7%
EGFPhi cells that were CD16+CD172a+ and expressed an increas-
ing level of CD14. The EGFPlo cells were more heterogeneous.
There was a wider range of CD14 expression than the EGFPhi cells,
and only a small percentage (,10%) also expressed CD16 and
CD172a (Fig. 2B). Leishman staining of sorted EGFP+ cells
revealed that the majority of cells were monocytoid. The large blast
cells were characteristic of myeloblasts and monoblasts (28)
(Fig. 2C).
Analysis of PBMCs from Csf1r-EGFP sheep
Peripheral blood monocytes in mice, humans, and pigs can be
divided into functional subsets based upon expression of surface
markers including CD14, CD16, CX3CR1, and CD163 (29–31).
Differentiation of these subsets appears to be controlled by the
macrophage growth factor, CSF1 (1, 2). Monocytes in MacGreen
mice are EGFP+ (4). To analyze EGFP expression in monocytes
from the sheep, blood samples were taken from live animals and
PBMCs purified using a density gradient. Sheep are known to
have a lower percentage of blood monocytes compared with hu-
mans or mice (32), and an average of 4.2% of PBMCs expressed
EGFP (range 1.2–9.9%). EGFP+ PBMCs could be divided into
EGFPhi and EGFPlo populations (Fig. 3A). The EGFPlo cells were
CD14++CD16+/2, characteristic of human classical and interme-
diate monocytes (33) whereas the EGFPhi cells displayed the
nonclassical monocyte phenotype (CD14+ CD16++). Both pop-
ulations expressed CD172a (Fig. 3B), and FSC could be used to
separate the EGFPhi cells into two distinct populations. Nonclas-
sical monocytes are known to be smaller than classical monocytes
(34), and Leishman staining on sorted cells revealed that both
subsets presented monocyte morphology (Fig. 3C). CD16+ human
monocytes express higher levels of Csf1r mRNA than CD162
monocytes (35), and this could be reflected in the increase in
EGFP expression in CD16+ monocytes from Csf1r-EGFP sheep.
Downregulation of the EGFP transgene in macrophages of
sheep
Treatment of BM cells or blood monocytes from other species with
CSF1 can promote maturation into macrophages in vitro (4, 21,
36). To analyze EGFP expression in macrophages from Csf1r-
EGFP sheep, we isolated AMs via lung lavage and PBMCs/BM
were differentiated in vitro in the presence of rhCSF1. The re-
sulting cell populations were analyzed for surface expression of
CD14, CD16, and CD172a. All three cell populations retained
high levels of surface CD14, but they differed in expression of
CD16 and CD172a. AMs were the only cell type to express CD16,
and BMDMs expressed very low levels of CD172a (Fig. 4). In all
of these populations of cells, detectable expression of the EGFP
transgene was extinguished. Hence the transgene provides a novel
marker for blood monocytes that is lost from mature macrophages.
To determine when EGFP expression was lost during differ-
entiation, we cultured BM cells in rhCSF1 and analyzed EGFP
expression via flow cytometry (Fig. 5A). After 24 h in culture with
rhCSF1, the EGFPhi population was no longer visible and 50% of
the cells expressed low levels of EGFP. This pattern of expression
continued until day 4, when there was a slight increase in the
granularity of the cells. After 7 d in culture, once the BM had
differentiated into macrophages, EGFP expression was no longer
detected. Expression of Csf1r mRNA is downregulated by CSF1
(37), and macrophages express lower levels of Csf1r compared
FIGURE 1. Monocytes of Csf1r-EGFP founder sheep express EGFP. (A) Confocal microscopy of Csf1r-EGFP sheep PBMCs (scale bar, 20 mm, rep-
resentative of four sheep) and EGFP PCR using genomic DNA from founder animals. (B) Representative flow cytometry analysis of CD14 and EGFP
expression in PBMCs from two founder sheep (i and ii). Cells were gated on lymphocytes and monocytes based on FSC/SSC. Propidium iodide was used to
exclude dead cells. NTC, no template control; +ve, plasmid DNA; 2ve, negative control sheep genomic DNA.
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with monocytes (38). Because the levels of EGFP in Csf1r-EGFP
sheep are very low, downregulation of Csf1r during differentiation
would likely result in loss of detectable EGFP. Indeed, comparison
of EGFP in PBMCs from Csf1r-EGFP sheep and mice demon-
strates the sheep express 1 log-fold less EGFP (Fig. 5B) and still
express EGFP mRNA in BMDMs (Fig. 5C). Mature macrophages
in Csf1r-EGFP mice are easily detected via FACS and microscopy
(4). Notwithstanding the lower expression, EGFP could still be
detected in the sheep macrophages via Western blot (Fig. 5D). As
we have previously shown that Csf1r-EGFP lentivirus is capable
FIGURE 2. BM of Csf1r-EGFP sheep contains a heterogeneous EGFP+ population of cells. BM from Csf1r-EGFP sheep was isolated from ribs and
analyzed via flow cytometry. (A) Gating strategy. Dead cells were excluded with propidium iodide staining and granulocytes excluded via FSC/SSC.
EGFPlo and EGFPhi were selected once quadrants were set with negative control BM. (B) Analysis of CD14, CD16, and CD172a expression in GFPlo and
GFPhi cells. Quadrants were set using isotype controls for each population. (C) Leishman-stained EGFP+ cells (combined EGFPlo and EGFPhi). Scale bar,
10 mm. Dot plots and Leishman staining of EGFP+ cells representative of five and two sheep, respectively. Leishman staining was representative of
15 images per animal.
FIGURE 3. Monocytes are EGFP+ in Csf1r-EGFP sheep. Peripheral blood monocytes were isolated from the blood of live animals and analyzed via flow
cytometry. (A) EGFP+ gating strategy. (B) Expression of CD14, CD16, and CD172a in EGFPlo and EGFPhi PBMCs. Quadrants were set using isotype
controls for each population. (C) Leishman-stained EGFP+ cells. Scale bars, 10 mm. Dot plots and Leishman staining of EGFP+ cells are representative of
nine and three sheep, respectively. Leishman staining was representative of 10 images per animal.
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of transducing primary sheep macrophages in vitro to generate
an EGFP+ population (12), producing Csf1r-EGFP sheep with a
higher titer of lentivirus may result in higher levels of EGFP+ in
macrophages.
Functional analyses of monocytes and macrophages from
Csf1r-EGFP sheep
MacGreen (Csf1r-EGFP) mice express the transgene in the same
locations as the endogenous gene (4). To verify whether expression
of the transgene in sheep was restricted to cells expressing Csf1r, we
used fluorescently labeled CSF1-Fc (6) to detect Csf1r in whole
blood via flow cytometry. Both EGFPhi and EGFPlo PBMCs bound
the labeled CSF1-Fc, whereas the EGFP2 PBMCs did not (Fig. 6A).
Surprisingly, the granulocyte population showed low levels of CSF1-
Fc binding. Murine granulocytes from the MacGreen mouse express
Csf1r mRNA and are EGFP+, yet they do not express Csf1r on the
cell surface (39). There is evidence that human granulocytes express
functional CSF1R, albeit at lower levels than CD14+ monocytes
(40). We examined EGFP expression in sheep granulocytes. Con-
sistent with the level of CSF1-Fc binding, and identical to the levels
of CSF1R in humans, this population expressed low levels of EGFP
(Fig. 6A). Expression of endogenous Csf1r was not affected by the
transgene; the level of mRNA detected by quantitative PCR in
BMDMs from wild type and transgenic sheep was not significantly
different (Fig. 6B).
BM and PBMCs from Csf1r-EGFP sheep differentiated into
macrophages in the presence of rhCSF1 (Figs. 4, 5). Phagocytosis
assays were performed to further investigate whether the transgene
had any effect on monocyte and macrophage function in Csf1r-
EGFP sheep. Both monocyte-derived macrophages (MDMs) and
BMDMs phagocytosed Zymosan A S. cerevisiae BioParticles
within 2 h (Fig. 6C), highlighting that they were indeed functional
macrophages. To compare the function of monocytes from wild
type and Csf1r-EGFP sheep, we performed phagocytosis assays on
whole blood. There was no difference in the capability of CD14+
monocytes to phagocytose E. coli (Fig. 6D), suggesting that the
transgene also had no effect on the function of monocytes.
The development of mature APCs relies on the expression of
surface MHC class II molecules. We assessed the expression in
wild type and transgenic monocytes via flow cytometry and found
FIGURE 4. Flow cytometry analysis of AMs, MDMs, and BMDMs from sheep. A lung lavage was performed to isolate AMs. Macrophages were
differentiated from PBMCs and BM for 7 d with rhCSF1. Dead cells were excluded with propidium iodide. Solid lines represent isotype controls. His-
tograms are representative of three (AM and MDM) or five (BMDM) sheep.
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that both groups had CD14+ monocytes that expressed MHC class II
(Fig. 6E). In humans, the highest expression levels of MHC class II
are found on CD16+ monocytes (30). As in humans, all monocytes
express high levels of MHC class II and it is unaffected in the
Csf1r-EGFP sheep. Again, in common with humans, the CD16+
monocytes expressed higher levels than the CD14++ subset.
Discussion
CSF1 controls the proliferation, differentiation, and survival of
monocytes and macrophages and their BM progenitors (41), and
the receptor, CSF1R, provides a marker for cells of the mono-
nuclear phagocyte lineage. MacGreen (Csf1r-EGFP) mice express
the transgene in the same locations as the endogenous gene, and
expression is dependent on FIRE (4). FIRE acts as an antisense
promoter in macrophages (42) and is remarkably conserved from
humans to reptiles (43). It is even more highly conserved than the
proximal promoter. We have recently described a lentivirus con-
taining control elements of murine Csf1r capable of driving
transgene expression in macrophages from multiple species, in-
cluding sheep, in vitro (12). This lentivirus was used in the gen-
eration of Csf1r-EGFP transgenic sheep. Alignment of the Ensembl
predicted sheep Csf1r gene with the murine promoter, and FIRE
reveals 50 and 80% identity, respectively (data not shown). All of
the myeloid-expressed transcription factor binding sites contained
within FIRE (44) are conserved between mouse and sheep. Our data
show that the apparent conservation reflects function in that the
mouse elements were sufficient to drive EGFP expression in mono-
cytes from all four Csf1r-EGFP founder sheep.
The Csf1r promoter region in mice contains two separate pro-
moters to drive expression in macrophages and placental tropho-
blast cells (45). In humans, the trophoblast promoter is located
26 kb upstream of CSF1R (46). When the human trophoblast pro-
moter sequence is aligned against the sheep genome (Oar_v3.1/
oviAri3) using BLAST-like alignment tool, the highest scoring
match is located at the 39 end of Pdgrfb. This suggests the ovine
trophoblast promoter, as in humans, is located at least 20 kb up-
stream of Csf1r. Deletion of the trophoblast promoter in the
MacBlue mice abolishes transgene expression in the majority of
tissue macrophages (10). Hence the lack of EGFP expression in
AMs from the transgenic sheep may be caused by the lack of the
trophoblast promoter in the construct used to generate these ani-
mals. We have previously shown that sheep macrophages are
EGFP+ after incubation with Csf1r-EGFP lentivirus, which used
polybrene to increase transduction efficiency (12). The low levels
of EGFP expression in Csf1r-EGFP sheep could likely be in-
creased by the use of a higher titer lentivirus (and hence more
lentiviral insertion events) or by use of the ovine instead of murine
Csf1r in the lentiviral construct. However, it is also possible that
the reduced expression level in sheep versus mouse is associated
with either species- or lentiviral-specific methylation of the trans-
gene. A study of EGFP+ sheep generated by lentiviral injection of
zygotes using a ubiquitous promoter indicated increased methyl-
ation patterns correlated with lower EGFP intensity (47).
Monocytes are a population of leukocytes that can be func-
tionally characterized by their ability to phagocytose, produce
cytokines, and present Ag. They make up 5–10% of the PBMCs in
humans and show both antigenic and morphological (size, gran-
ularity, and nuclear morphology) heterogeneity. Their initial iden-
tification was based on expression of CD14; however, variation in
surface expression of Ags has led to the description of various
subsets (reviewed in Ref. 48). Human and bovine monocytes can
be divided into subpopulations based on surface expression of
FIGURE 5. Downregulation of EGFP expression during macrophage differentiation. (A) Cryopreserved BM from wild type and Csf1r-EGFP sheep were
cultured in rhCSF1 and then analyzed via flow cytometry for EGFP. Monocyte precursors were gated via FSC/SSC profiles and dead cells excluded with
propidium iodide. Dot plots are representative of two sheep. (B) Flow cytometry analysis of EGFP expression in monocytes from Csf1r-EGFP mice (solid
black) and sheep (solid gray) compared with wild type animals. Monocytes were gated via FSC/SSC profiles. Histograms are representative of three
animals. (C) mRNAwas prepared from wild type (2ve) and Csf1r-EGFP (+ve) BMDMs and used in RT-PCR to analyze EGFP expression. Each image is
representative of three experiments. (D) Protein lysates from BMDMs were analyzed via Western blot for EGFP and ACTB expression. Blot is repre-
sentative of two experiments.
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CD14/CD16, whereas porcine and murine monocytes can be iden-
tified by CD14/CD163 and Ly6C/CX3CR1, respectively (reviewed
in Ref. 19). The majority of knowledge about monocyte devel-
opment in the BM stems from work performed in mice (reviewed
in Ref. 49). Monocytes develop from hemopoietic stem cells in the
BM via a series of progenitors such as the common myeloid
progenitor, monocyte-macrophage dendritic cell progenitor, and
the common monocyte progenitor, which all express Csf1r (50–
53). These progenitors can be identified as Lin2 and by differ-
ential expression of CD117 (c-kit), CX3CR1, Ly6C, and CD31. In
humans, the common myeloid progenitor can be distinguished
from other progenitors based on expression of CD38, CD45RA,
FLT3, CD7, and CD10 (54). In-depth studies of monocyte de-
velopment in larger animals have been hampered by the lack of
species-specific Abs. In pigs, the Swine Workshop Cluster mole-
cules were originally used to identify committed monocyte pre-
cursors in the BM. Swine Workshop Cluster 3 was identified as the
earliest marker of myeloid cell development (55) and was later
identified as CD172a (56). In cows and sheep, CD34+ progenitor
cells have been identified (57, 58), yet specific analysis of monocyte
progenitors has not been performed.
As noted earlier, the expression of the EGFP transgene in the
sheep is downregulated by CSF1 in vitro and in tissue macrophages
in vivo. Tissue macrophages depend upon CSF1 for their differ-
entiation, and they are rapidly depleted after treatment of mice with
anti-CSF1R Ab (5). The downregulation of the reporter gene by
CSF1 probably reflects direct actions on FIRE. FIRE enhancer
activity is acutely regulated by transcription factor Runx1, which
is expressed at high levels in progenitors and acutely downregu-
lated by CSF1 (59). There is an emerging view that most tissue
macrophages are replaced by self-renewal, rather than replace-
ment from the blood monocyte pool (60, 61). Like the MacBlue
transgene in mice, which is effectively monocyte specific (62, 63),
the Csf1r-EGFP lentiviral transgene could provide a useful marker
to monitor monocyte extravasation and trafficking in tissues, and
might be applied to other species.
Mice and humans differ immunologically, and the mouse has
limitations as a model (64–66). Macrophages from the pig more
closely resemble those of humans in terms of their response to
bacterial LPS (21) or sheep in terms of pattern recognition re-
ceptor expression (67). Hence larger animal models are likely to
represent a better model of human macrophage development.
Phenotypic analysis of macrophage development in sheep has not
been described. Instead, studies have focused on the response of
monocytes and macrophages to infection. We have shown that
monocytes from Csf1r-EGFP sheep are functional and comparable
with their wild type counterparts, and that the transgene had no
effect on expression of the endogenous gene. Hence, as expression
of Csf1r is one of the earliest markers of macrophage lineage
commitment (51), BM from Csf1r-EGFP sheep could be a valu-
able resource to study the earliest events in myelopoiesis in an
underused species.
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FIGURE 6. (A) Freshly isolated blood from wild type and Csf1r-EGFP sheep was analyzed via flow cytometry for binding of CSF1-Fc and EGFP
expression. PBMCs and granulocytes were gated via FSC/SSC profiles and dead cells excluded with Zombie Violet. Quadrants were set with wild type
sheep blood. Dot plots are representative of three Csf1r-EGFP sheep and two repeat experiments. (B) Quantitative PCR was used to determine the fold
change of Csf1r expression between wild type and Csf1r-EGFP sheep BMDMs (n = 4 per group). (C) PBMCs from Csf1r-EGFP sheep were differentiated
into macrophages with rhCSF1. Phagocytosis assays performed with Zymosan A S. cerevisiae BioParticles and viewed by confocal microscopy. Images are
representative of two MDMs and two BMDMs. Scale bars, 20 mm. (D) Phagocytosis assays were performed on freshly drawn blood from Csf1r-EGFP
sheep and wild type controls using pHrodo Red E.coli BioParticles. CD14+ monocytes were gated in the PBMC fraction by flow cytometry. Results are
representative of four wild type and six Csf1r-EGFP sheep. The control contained BioParticles and was incubated on ice. (E) Representative histograms of
MHC class II expression in CD14+ PBMCs from wild type (n = 5) and Csf1r-EGFP (n = 7) sheep, analyzed by flow cytometry. (F) Representative his-
tograms of MHC class II expression in CD14+ and CD16+ (GFPhi) monocytes from Csf1r-EGFP sheep (n = 5), analyzed by flow cytometry.
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